|
CA3024869A1
|
|
Glycoengineering of e-selectin ligands
|
|
AU2016210780A1
|
|
Compositions and methods for modifying cell surface glycans
|
|
AU2014202669A1
|
|
Compositions and methods for modifying cell surface glycans
|
|
WO2012151576A1
|
|
Methods of treating complications and disorders associated with g-csf administration
|
|
US2009053198A1
|
|
Cytokine induction of selectin ligands on cells
|
|
EP3336174A1
|
|
Compositions and methods for modifying cell surface glycans
|
|
US2006210558A1
|
|
Hematopoietic cell selectin ligand polypeptides and methods of use thereof
|
|
US2006003924A1
|
|
Sulfation-independent L-selectin or E-selectin ligand (HCELL) and therapeutics thereof
|
|
US7875585B2
|
|
Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide
|
